Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
38,555,821
-
Shares change
-
-1,695,600
-
Total reported value, excl. options
-
$407,535,405
-
Value change
-
-$67,673,203
-
Put/Call ratio
-
24.58%
-
Number of buys
-
66
-
Number of sells
-
-60
-
Price
-
$10.57
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2021
163 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,555,821 shares
of 202,731,676 outstanding shares and own 19.02% of the company stock.
Largest 10 shareholders include STATE STREET CORP (4,390,637 shares), VANGUARD GROUP INC (4,000,697 shares), Woodline Partners LP (3,750,575 shares), EVENTIDE ASSET MANAGEMENT, LLC (3,370,994 shares), BlackRock Inc. (3,102,787 shares), Alpine Global Management, LLC (2,000,000 shares), MORGAN STANLEY (1,542,351 shares), TWO SIGMA INVESTMENTS, LP (1,275,149 shares), BVF INC/IL (1,273,516 shares), and BOXER CAPITAL, LLC (1,000,000 shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.